Mateusz Kaczmarek, Author at TechStock²

Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Company Overview & Stock Snapshot Pfizer Inc. is one of the world’s largest pharmaceutical companies, known for household-name drugs and vaccines. Headquartered in New York, Pfizer manufactures treatments across vaccines, oncology, immunology, cardiology, and more. The company gained global prominence

5 November 2025

Business News·Healthcare Industry·Investing·Pharmaceuticals·Stock Market

Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Stock Performance and Recent Trends (Past Week) Cipher Mining’s stock has been on a tear. In the final week of October into early November 2025, CIFR rocketed from the high teens to the mid-$20s per share Stockanalysis Stockanalysis. On Monday,

5 November 2025

Cryptocurrency·Earnings Reports·Investment Insights·Market Analysis·Stocks

Rubico (RUBI) Stock in Freefall: Top Ships Spin-Off Collapses 90% – What Investors Should Know

Company Overview: Business Model & Background Rubico Inc. is a Marshall Islands-incorporated shipping company providing crude oil transportation services via a small fleet of tankers Globenewswire Globenewswire. The company was created as a spin-off from TOP Ships Inc., a Greek

5 November 2025

Company Analysis·Financial News·Investing·Stock Market

First Majestic Silver (AG) Shines on Silver’s Surge – But Can the Rally Sustain?

Stock Performance and Technical Trends First Majestic’s stock has had a rollercoaster year, skyrocketing through 2025 alongside the price of silver. The share price climbed from the ~$5 level in January to a 52-week high of $15.69 by late October

5 November 2025

Investment Strategies·Market Trends·Precious Metals·Silver Market·Stock Analysis

Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Stock Price & Recent Performance 📈 Rigel’s stock has been on a tear in 2025, reflecting its improving fundamentals. As of November 5, 2025, RIGL trades around $38/share, up over 30% in a single day after its blowout Q3 earnings

5 November 2025

Analyst Insights·Earnings Reports·Pharmaceutical Industry·Stock Market News

Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Recent News: Earnings Spark Rally Lumentum’s San Jose headquarters. The company’s stock jumped after it announced record quarterly revenue and upbeat guidance, fueled by surging demand from AI data centers. Lumentum made headlines on November 4–5, 2025 with a stellar

5 November 2025

AI Technology·Earnings Reports·Financial News·Investment·Stock Market

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

1. Company Background and Overview of Kratos Defense & Security Solutions, Inc. Kratos Defense & Security Solutions, Inc. is a U.S. technology company serving the defense and national security market. Founded in 1994 and headquartered in San Diego, Kratos specializes

5 November 2025

Aerospace Industry·Drone Technology·Investment Trends·Stock Market Analysis

Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

(Each of these points is explored in detail below.) Company Overview Babcock & Wilcox Enterprises, Inc. (“B&W”) is an American energy technology and services provider with a 158-year legacy. Headquartered in Akron, Ohio, the company is historically renowned for its

5 November 2025

Artificial Intelligence·Earnings Reports·Energy Industry·Investment Analysis·Stock Market

Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Market Performance and Recent Stock Price Trex stock has endured a steep slide in 2025, culminating in a dramatic plunge after its early November earnings announcement. On November 5, 2025, TREX opened around $34–35 per share – down roughly 26%

5 November 2025

Business Analysis·Earnings Reports·Home Improvement·Investing·Stock Market

From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

Company Overview: AI-Powered Biotech at the Intersection of Therapeutics & Biodefense Lunai Bioworks Inc. is a pre-clinical stage biotechnology company pioneering an unusual dual focus: AI-driven drug discovery and biodefense. The company’s mission is to “capture biological signals at scale,

5 November 2025

Biotechnology·Company Analysis·Innovation·Investing·Stock Market

Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

FDA Setback: Complete Response Letter Halts Lead Drug Ambitions Biohaven’s recent troubles center on VYGLXIA (troriluzole) – its lead drug candidate for spinocerebellar ataxia (SCA), a degenerative brain disorder that currently has no approved treatment Reuters. On November 4, 2025,

5 November 2025

Biotech·Investing·Pharmaceuticals·Stocks

Why Zeta Global (ZETA) Stock Is Soaring: 17 Straight Beats, AI Power, and Big Upside Ahead

Latest News & Catalysts (Early November 2025) Zeta Global made headlines on November 4, 2025 by reporting stellar third-quarter results and raising its guidance for the 17th straight quarter Zetaglobal. The Q3 earnings release showed better-than-expected revenue and profits, prompting

5 November 2025

Artificial Intelligence·Earnings Reports·Investment Strategies·Stock Market·Technology Stocks